Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae

被引:6
|
作者
Cremanns, Martina [1 ]
Lange, Felix [1 ,2 ]
Gatermann, Soeren G. [1 ]
Pfennigwerth, Niels [1 ]
机构
[1] Ruhr Univ Bochum, German Natl Reference Ctr Multidrug Resistant Gra, Dept Med Microbiol, Univ Str 150, D-44801 Bochum, Germany
[2] Landeszentrum Gesundheit Nordrhein Westfalen, Fachgrp Infekt Epidemiol, Gesundheitscampus 10, D-44801 Bochum, Germany
关键词
BETA-LACTAM RESISTANCE; ESCHERICHIA-COLI; EXTRACYTOPLASMIC STRESS; MOLECULAR-MECHANISMS; PORIN EXPRESSION; READ ALIGNMENT; OMPK36; RSEA; RESPONSES; ENVELOPE;
D O I
10.1093/jac/dkac078
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives Resistance levels of Gram-negative bacteria producing OXA-48 carbapenemase can vary greatly and some of them can even be categorized as susceptible to imipenem and meropenem according to EUCAST breakpoints. This study aimed to reveal resistance mechanisms leading to varying levels of resistance to carbapenems in Klebsiella pneumoniae with bla(OXA-48) submitted to the German National Reference Centre for MDR Gram-negative bacteria. Methods Meropenem-susceptible clinical bla(OXA-48)-bearing K. pneumoniae isolates were put under gradually increasing selective pressure of meropenem. Clinical isolates and spontaneous meropenem-resistant mutants were whole-genome sequenced with Illumina and Oxford Nanopore Technology. Identified mutations apart from porin mutations were genetically constructed in the original clinical isolates using CRISPR/Cas. Clinical isolates and mutants were analysed for MICs, growth rates and expression of porins on mRNA and protein levels. Results Mutations associated with meropenem resistance were predominantly found in ompK36, but in some cases ompK36 was unaffected. In two mutants, ISs within the rpoE (sigma factor E; sigma(E)) operon were detected, directly in or upstream of rseA. These IS1R elements were then inserted into the same position of the susceptible clinical isolates using CRISPR/Cas. CRISPR-rseA-rseB-rseC mutants showed higher resistance levels to carbapenems and cephalosporins, reduced growth rates and reduced expression of major porins OmpK36 and OmpK35 in quantitative RT-PCR and SDS-PAGE. Conclusions Enhanced synthesis of sigma(E) leads to increased resistance to cephalosporins and carbapenems in clinical K. pneumoniae isolates. This effect could be based upon remodelling of expression patterns of outer membrane proteins. The up-regulated sigma(E) stress response also leads to a significant reduction in growth rates.
引用
收藏
页码:1578 / 1585
页数:8
相关论文
共 50 条
  • [1] Urban pigeons as a reservoir of carbapenem resistant Enterobacterales: first report of OXA-48-producing Klebsiella pneumoniae
    Loucif, Lotfi
    Chelaghma, Widad
    Bendjama, Esma
    Bouaziz, Amira
    Cherak, Zineb
    Serrar, Wissam
    Mohammed, Faiza Si
    Rolain, Jean-Marc
    NEW MICROBES AND NEW INFECTIONS, 2022, 47
  • [2] Detection and characterization of OXA-48-producing Klebsiella pneumoniae originated in Bulgaria
    Sabtcheva, Stefana
    Ivanov, Ivan N.
    Todorova, Bozhana
    Simeonov, Yordan
    Dobreva, Elina
    Ivanova, Krasimira
    Velinov, Tzvetan
    Kantardjiev, Todor
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (05) : 450 - 453
  • [3] Characterization of Isolates Associated with Emergence of OXA-48-Producing Klebsiella pneumoniae in Croatia
    Jelic, Marko
    Skrlin, Jasenka
    Bejuk, Danijela
    Koscak, Iva
    Butic, Iva
    Guzvinec, Marija
    Tambic-Andrasevic, Arjana
    MICROBIAL DRUG RESISTANCE, 2018, 24 (07) : 973 - 979
  • [4] Disinfecting Action of Gaseous Ozone on OXA-48-Producing Klebsiella pneumoniae Biofilm In Vitro
    Piletic, Kaca
    Kovac, Bruno
    Percic, Marko
    Zigon, Jure
    Broznic, Dalibor
    Karleusa, Ljerka
    Blagojevic, Sanja Lucic
    Oder, Martina
    Gobin, Ivana
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (10)
  • [5] Environmental persistence of OXA-48-producing Klebsiella pneumoniae in a French intensive care unit
    Pantel, Alix
    Richaud-Morel, Brigitte
    Cazaban, Michel
    Bouziges, Nicole
    Sotto, Albert
    Lavigne, Jean-Philippe
    AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (03) : 366 - 368
  • [6] Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain
    Oteo, Jesus
    Manuel Hernandez, Juan
    Espasa, Mateu
    Fleites, Ana
    Saez, David
    Bautista, Veronica
    Perez-Vazquez, Maria
    Dolores Fernandez-Garcia, Ma
    Delgado-Iribarren, Alberto
    Sanchez-Romero, Isabel
    Garcia-Picazo, Luisa
    Dolores Miguel, Ma
    Solis, Sonia
    Aznar, Esteban
    Trujillo, Gloria
    Mediavilla, Concepcion
    Fontanals, Dionisia
    Rojo, Susana
    Vindel, Ana
    Campos, Jose
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (02) : 317 - 321
  • [7] High-Level Carbapenem Resistance among OXA-48-Producing Klebsiella pneumoniae with Functional OmpK36 Alterations: Maintenance of Ceftazidime/Avibactam Susceptibility
    Lumbreras-Iglesias, Pilar
    Rodicio, Maria Rosario
    Valledor, Pablo
    Suarez-Zarracina, Tomas
    Fernandez, Javier
    ANTIBIOTICS-BASEL, 2021, 10 (10):
  • [8] In Vitro Synergism of Azithromycin Combination with Antibiotics against OXA-48-Producing Klebsiella pneumoniae Clinical Isolates
    Singkham-in, Uthaibhorn
    Muhummudaree, Netchanok
    Chatsuwan, Tanittha
    ANTIBIOTICS-BASEL, 2021, 10 (12):
  • [9] Transmission and evolution of OXA-48-producing Klebsiella pneumoniae ST11 in a single hospital in Taiwan
    Lu, Min-Chi
    Chen, Ying-Tsong
    Tang, Hui-Ling
    Liu, Yen-Yi
    Chen, Bo-Han
    Wang, You-Wun
    Chen, Yi-Syong
    Teng, Ru-Hsiou
    Hong, Yu-Ping
    Chiou, Chien-Shun
    Chiang, Ming-Ko
    Lai, Yi-Chyi
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (02) : 318 - 326
  • [10] In vivo efficacy of enmetazobactam combined with cefepime in a murine pneumonia model induced by OXA-48-producing Klebsiella pneumoniae
    Albac, S.
    Anzala, N.
    Chavanet, P.
    Dunkel, N.
    Quevedo, J.
    Henriksen, A. Santerre
    Croisier, D.
    MICROBIOLOGY SPECTRUM, 2024, 12 (12)